Dr. Silvia Corvera's lab focuses on understanding how human adipose (fat) tissue regulates metabolism and energy balance, especially in the context of diseases like Type 2 Diabetes. By studying the activities of different types of human fat cells in laboratory models, they aim to uncover the mechanisms that control fat storage and energy expenditure, which are crucial for preventing metabolic disorders. Their groundbreaking research includes techniques to develop functional human fat in mice, allowing for innovative studies on fat cell behavior and the effects of specific genes on metabolism.

Dr. Susan L. Swain's lab at the University of Massachusetts Medical School focuses on understanding how aging affects the immune response to influenza. The research particularly examines a unique population of B cells that may help protect older adults from flu infections. By studying how these cells respond to different types of vaccines, the lab aims to improve vaccine efficacy for the elderly, who are particularly vulnerable to flu and other viruses like COVID-19.

Dr. Danny Winder's research lab focuses on understanding how alcohol affects sleep and the brain's arousal pathways, especially in individuals with alcohol use disorders. Their work aims to uncover the complex mechanisms linking alcohol consumption with sleep disturbances, using advanced techniques to analyze how specific brain pathways are influenced by alcohol. This research is important for developing better treatments for sleep issues related to alcohol dependence.

Dr. Gowthaman Uthaman's lab at the University of Massachusetts Medical School focuses on understanding how specific immune cells contribute to allergenic responses in the body. The research particularly investigates a novel type of T helper cell, called Tfh13 cells, which are vital in producing IgE antibodies responsible for dangerous allergic reactions. By studying these cells, the lab aims to discover new ways to prevent or treat severe allergies and anaphylaxis.

Dr. Ying Leong Chan's lab at the University of Massachusetts focuses on understanding how exposure to heavy metals, like cadmium, influences Alzheimer's disease. They use innovative human-derived brain models to explore how genetic factors and viral infections, specifically the herpes simplex virus, might interact to accelerate Alzheimer's-related changes in the brain. The work aims to uncover new insights into the disease's causes and develop potential treatment approaches.

Eduardo Martin Torres's lab investigates how an abnormal number of chromosomes affects cell function, particularly in Down syndrome. Their research seeks to understand the mechanisms that link aneuploidy (having an incorrect number of chromosomes) to developmental and aging-related issues in patients. The team focuses on cell structure, especially the nuclear membrane, to discover pathways that might help suppress negative effects associated with Down syndrome and promote health in affected individuals.

Eric H Baehrecke's lab at the University of Massachusetts Medical School studies the process of autophagy, which is how cells recycle and dispose of cellular waste. The research focuses on understanding how autophagy is regulated during the development of the fruit fly (Drosophila), providing insights that could help us understand similar processes in humans and how they are linked to diseases like cancer and neurodegeneration. By studying autophagy in specific cell types in the intestines, the lab aims to uncover how different cellular components are selected for degradation, which could lead to new therapeutic strategies for human health.

Dr. A. M. Barrett's lab focuses on understanding how medication self-administration (MSA) can indicate early signs of cognitive impairment, including Alzheimer's Disease. By studying individuals in the Framingham Heart Study, the lab aims to link errors in medication management and self-assessment of these abilities to cognitive decline and brain health. Their research has significant implications for improving caregiving practices and adjusting healthcare approaches for the aging population.

Dr. Michael Czech's lab focuses on understanding how certain fat cells, called beige adipocytes, can improve metabolic health in conditions like obesity and diabetes. They use advanced CRISPR technology to convert regular fat cells into beige adipocytes, which can help in weight loss and improve body metabolism. The lab's research aims to discover the underlying mechanisms that allow these fat cells to help the body utilize energy better and combat fat accumulation in the liver.

Dr. Jennifer A Benanti's lab studies how cells grow and divide, focusing specifically on the cell cycle, which is crucial for normal development and cancer prevention. By investigating molecular mechanisms, particularly the role of phosphorylation, her research aims to uncover how cells respond to stress and how mutations can contribute to diseases like cancer. Overall, her work seeks to find new strategies for controlling cellular proliferation and improving therapeutic approaches in oncology.

Dr. Jae-Hyuck Shim's lab focuses on understanding and treating bone loss diseases, particularly in the context of inflammatory arthritis and osteogenesis imperfecta (a genetic disorder leading to fragile bones). They develop innovative gene therapies using specialized viruses to enhance bone health by targeting specific proteins that regulate bone formation. Through their research, they aim to discover new treatments that could improve patient outcomes in these conditions.

Dr. Vanni Bucci's lab focuses on developing innovative therapies aimed at enhancing the health of the intestinal barrier to help people affected by severe radiation exposure. They explore how the gut microbiome—the collection of bacteria and microorganisms in our intestines—can be harnessed to prevent damage from radiation. The lab works on engineering probiotics and designing dietary interventions that support the microbiome, promoting better recovery and survival following acute radiation syndrome (GI-ARS).

Dr. Elinor Karlsson's lab focuses on using pet dogs with spontaneous cancer to improve blood tests that can detect cancer-related genetic changes. By studying how dog cancer mirrors human cancer, the lab aims to develop better techniques for monitoring cancer through blood samples. Their work has the potential to influence how we screen for cancer and monitor its progression in humans.

The Rhind lab at the University of Massachusetts Medical School focuses on understanding how cells control their growth and division, particularly in the context of size homeostasis and DNA replication. They explore questions such as how cells decide when to divide and how they manage the timing of DNA replication, which are critical for maintaining genome stability and preventing diseases like cancer. Using model organisms like fission yeast, the lab aims to unravel the mechanisms behind these essential cellular processes, which have implications for understanding human health and disease.

Dr. Feifan Liu's lab focuses on using artificial intelligence and machine learning to improve cardiovascular disease risk prediction, particularly for populations that face health disparities. By integrating social determinants of health with clinical factors, the lab aims to create models that can guide better health interventions and promote health equity. Their work is relevant not only for researchers but also for practitioners looking to address health inequalities in their communities.

Dr. Jeanne Bentley Lawrence's lab studies how an extra copy of chromosome 21 impacts cellular processes related to Down Syndrome and early-onset Alzheimer's disease. They focus on understanding the roles of non-coding RNAs and how they contribute to cell development and brain function. The lab employs innovative methods to investigate the molecular underpinnings of these conditions, aiming to inform therapeutic strategies that may be able to correct cognitive deficits associated with Down Syndrome.

The research lab of Job Dekker at the University of Massachusetts Medical School focuses on understanding how the human genome is organized and regulated. His team investigates how the three-dimensional structure of chromosomes affects gene expression and stability, and how defects in this organization can lead to diseases such as cancer. By employing cutting-edge genomic technologies, they explore the molecular mechanisms that facilitate proper chromosome folding and segregation during the cell cycle.

Dr. Roger J. Davis's lab at the University of Massachusetts Medical School focuses on understanding how obesity impacts metabolic health. The research specifically investigates the role of JNK signaling pathways in fat tissue, aiming to uncover how these pathways contribute to inflammation and insulin resistance associated with obesity. By identifying molecular mechanisms involved in these processes, the lab seeks to inform new treatment strategies for metabolic syndrome and type 2 diabetes.

Dr. Ben Steven Gerber's lab focuses on improving diabetes management, specifically for individuals with type 2 diabetes in underserved communities. The lab conducts research on continuous glucose monitoring (CGM) technology and combines it with the expertise of clinical pharmacists and community health workers to enhance patient care. Their work aims to evaluate the effectiveness and cost-efficiency of this integrated approach in primary care settings, ultimately seeking to improve health outcomes for diverse populations.

Dr. Andrew R. Tapper's lab focuses on understanding how stress affects motivation for reward-seeking behaviors, particularly through the brain's dopaminergic pathways. By exploring specific neuronal circuits in the interpeduncular nucleus, the research aims to uncover how stress can influence reward-related behaviors, which may provide insights into the underlying mechanisms of neuropsychiatric disorders. The lab employs cutting-edge techniques to study these complex interactions in animal models, contributing to the development of potential new treatments.